Browsing Tag
Goldman Sachs
162 posts
Oxylabs bets $3.6bn valuation on agentic AI web data infrastructure thesis
Warburg Pincus injects $130 million into Oxylabs at a $3.6 billion valuation, but can agentic AI data infrastructure defend that private-market benchmark?
Frasers Group (LSE: FRAS) crosses 30% HUGO BOSS threshold as €38 takeover offer enters final week
Frasers Group has moved beyond Germany’s mandatory takeover threshold, but HUGO BOSS shareholder resistance and Frasers’ rising debt leave the final ownership outcome unresolved.
Eli Lilly (NYSE: LLY) to acquire AtaiBeckley in $3.8bn TRD psychedelic deal
Eli Lilly (NYSE: LLY) to acquire AtaiBeckley for $6.75/share cash plus $2.50 CVR, taking the BPL-003 5-MeO-DMT depression asset to Phase 3 read in 2029.
Goldman Sachs stock (NYSE: GS) jumps 7.6% after record quarter: can the gains last?
Goldman Sachs reported record quarterly revenue and EPS as equities trading, underwriting and dealmaking accelerated. With $GS near a 52-week high and valued above three times book value, the next test is whether elevated returns can continue.
Qorvo (NASDAQ: QRVO) signs worldwide distribution pact with Rochester Electronics on defense RF
Qorvo (NASDAQ: QRVO) signs Rochester Electronics deal for long-term RF supply, deepening its defense positioning before the Skyworks merger closes in 2027.
IBM (NYSE: IBM) Q2 miss triggers 25% drop as mainframe cycle wrap bites
IBM (NYSE: IBM) drops up to 25% after preliminary Q2 revenue of $17.2bn misses by $660m; Krishna concedes execution slip before the July 22 earnings call.
Ionis Pharmaceuticals (IONS) drops 21% as Wainua Phase 3 ATTR-CM trial fails, Alnylam Amvuttra and BridgeBio Attruby emerge as clear beneficiaries
Ionis (IONS) drops 21% as Wainua Phase 3 ATTR-CM trial fails primary endpoint. Peak sales cut to $4B. Alnylam and BridgeBio benefit from the reset.
SK Hynix files SEC prospectus for biggest ever US listing by a foreign company, targets $28 billion
SK Hynix launches $28 billion Nasdaq ADR listing under symbol SKHY, set to trade July 10 in the biggest ever US listing by a foreign company. Read more.
Solstice to buy Element Solutions for $14.5bn as AI materials strategy faces investor test
Solstice Advanced Materials is using stock, cash and new debt to acquire Element Solutions, creating a larger supplier across semiconductor fabrication, advanced packaging, electronics and data center cooling. The deal offers substantial strategic reach, but Solstice’s sharp share-price decline has already reduced the value available to Element Solutions shareholders.
Goldman Sachs raises Robinhood (Nasdaq: HOOD) price target to $121 after record June trading volumes
Goldman Sachs raises its Robinhood price target to $121 as prediction markets revenue crosses $400 million annualized, just 18 months after launch.